Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_assertion type Assertion NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_head.
- NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_assertion description "[Immunohistochemical analysis of NDRG2 protein in 100 HCC patient tissues indicated that NDRG2 expression loss is significantly correlated with aggressive tumor behaviors such as late tumor-node-metastasis (TNM) stage (P = 0.012), differentiation grade (P = 0.024), portal vein thrombi (P = 0.011), infiltrative growth pattern (P = 0.015), nodal/distant metastasis (P = 0.027), and recurrent tumor (P = 0.021), as well as shorter patient survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_provenance.
- NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_assertion evidence source_evidence_literature NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_provenance.
- NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_assertion SIO_000772 18519680 NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_provenance.
- NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_assertion wasDerivedFrom befree-20150227 NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_provenance.
- NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_assertion wasGeneratedBy ECO_0000203 NP930256.RA7eUUgk6VhQcIZJnWfIShgAN9nEVyNI6A449JvhJEFGQ130_provenance.